Drug intelligence / Profile preview

Qinghouyan lozenges

Development stage: Unknown
Lead developer: Suzhou Youseen New Drug R&D
Administration: Oral

Overview

Qinghouyan lozenges is a Traditional Chinese Medicine (TCM) therapeutic developed by Shanghai Yusen New Drug Development Co., Ltd. for the treatment of acute pharyngitis and acute catarrhal tonsillitis. It is a solid dosage form (lozenge) derived from the Qinghouyan mixture, a formula traditionally used to treat lung heat with yin deficiency patterns in TCM. The preparation typically contains botanical extracts aimed at clearing heat, detoxifying, and soothing the throat. Clinical evaluation has focused on its efficacy and safety compared to the liquid mixture formulation in adult patients, specifically targeting the TCM pattern of lung heat with yin deficiency.

Brand names: Qinghouyan lozenges
Other names: 清喉咽含片

Beyond the preview

Go deeper on Qinghouyan lozenges.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qinghouyan lozenges.

Explore the full profile